- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 15:02 | Bullion Gold Resources Corporation: Bullion Gold Announces the Appointment of Simon Britt as President and Chief Executive Officer | 210 | Newsfile | Montreal, Quebec--(Newsfile Corp. - April 13, 2026) - Bullion Gold Resources Corp. (TSXV: BGD) ("the Company" or "Bullion") is pleased to announce the appointment of Mr. Simon Britt as President... ► Artikel lesen | |
| Fr | Bullion Gold Resources Corp (2): Bullion Gold completes diamond drilling at Langlade | 3 | Stockwatch | ||
| Do | Bullion Gold Resources Corporation: Bullion Gold Completes Drilling Program on Langlade Project | 246 | Newsfile | Montreal, Quebec--(Newsfile Corp. - April 9, 2026) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Company") is pleased to announce that it has successfully completed its diamond... ► Artikel lesen | |
| BULLION GOLD RESOURCES Aktie jetzt für 0€ handeln | |||||
| 31.03. | Bullion Gold Resources Corporation: 19.40m @ 17.29 g/t Au in Hole BO-26-63 at Bousquet | 363 | Newsfile | Montreal, Quebec--(Newsfile Corp. - March 31, 2026) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Corporation") and its partner Olympio Metals are pleased to announce the final... ► Artikel lesen | |
| 24.03. | Bullion Gold Resources Corp (2): Bullion Gold drills 7.5 m of 41.81 g/t Au at Bousquet | 2 | Stockwatch | ||
| 23.03. | Bullion Gold Resources Corporation: Bonanza Gold Intercept from Phase 2 Drilling at Bousquet | 470 | Newsfile | Montreal, Quebec--(Newsfile Corp. - March 23, 2026) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Corporation") is pleased to announce first assay results from the Phase 2 drilling... ► Artikel lesen | |
| 05.03. | Bullion Gold Resources Corp (2): Bullion Gold plans 25,000 m drill program at Terragold | 3 | Stockwatch | ||
| 05.03. | Bullion Gold Resources Corporation: Bullion Gold Plans a 25,000 M Drilling Program on Its Terragold Project | 436 | Newsfile | Montreal, Quebec--(Newsfile Corp. - March 5, 2026) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Company") is currently preparing an application for a forestry intervention... ► Artikel lesen | |
| 26.02. | Bullion Gold Resources Corporation: Bullion Gold Obtains Drilling Permits for the Langlade Project | 385 | Newsfile | Montreal, Quebec--(Newsfile Corp. - February 26, 2026) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Corporation") announces that it has received approval from the Quebec Ministry... ► Artikel lesen | |
| 17.02. | Bullion Gold Resources Corporation: Diamond Drilling Intersects Multiple Visible Gold Occurrences at the Bousquet Gold Project | 563 | Newsfile | Montreal, Quebec--(Newsfile Corp. - February 17, 2026) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Company") and it's partner Olympio Metals are pleased to announce that the... ► Artikel lesen | |
| 13.02. | Bullion Gold Resources Corp (2): Bullion Gold restarts drilling at Bousquet project | 1 | Stockwatch | ||
| 12.02. | Bullion Gold Resources Corporation: Drilling Resumes at Bousquet Gold Project, Quebec | 331 | Newsfile | Montréal, Québec--(Newsfile Corp. - February 12, 2026) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Company") is pleased to announce that it's partner Olympio Metals ("Olympio")... ► Artikel lesen | |
| 12.02. | XFRA NEW INSTRUMENTS AVAILABLE ON 12.02.2026 | 392 | Xetra Newsboard | The following instruments on XETRA do have their first trading 12.02.2026 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 12.02.2026
Aktien
1 CA13723D1006 Canasil Resources Inc.
2... ► Artikel lesen | |
| 03.02. | Bullion Gold Resources Corp (2): Bullion Gold acquisition of Abitibi mining claims | 1 | Stockwatch | ||
| 27.01. | Bullion Gold Resources Corp (2): Bullion Gold takes 100% ownership of Terragold | 2 | Stockwatch | ||
| 26.01. | Bullion Gold Resources Corporation: Bullion Gold Acquires 100% of the Terragold Project and Consolidates a Strategic Gold Asset | 318 | Newsfile | Montreal, Quebec--(Newsfile Corp. - January 26, 2026) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Company") is pleased to announce the signing of an amendment to the original... ► Artikel lesen | |
| 09.01. | Bullion Gold Resources Corp (2): Bullion Gold private placement | 2 | Stockwatch | ||
| 06.01. | Bullion Gold Resources Corporation: High-Grade Gold up to 12.2 g/t Intersected in Multiple Structures at Bousquet | 573 | Newsfile | Montreal, Quebec--(Newsfile Corp. - January 6, 2026) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Corporation") is pleased to announce further assay results for the Bousquet... ► Artikel lesen | |
| 24.12.25 | Bullion Gold Resources Corp (2): Bullion Gold closes $300,000 private placement | 2 | Stockwatch | ||
| 23.12.25 | Bullion Gold Resources Corporation: Bullion Gold Completes Private Placement | 456 | Newsfile | Montreal, Quebec--(Newsfile Corp. - December 23, 2025) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Corporation") announces that it has closed a private placement (the "Offering")... ► Artikel lesen |
1 2 3 Weiter >>
44 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| QIAGEN | 35,350 | +0,91 % | QIAGEN N.V.: Qiagen Announces Form 20-F Annual Report Filing for 2025 Results | QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that it has filed its annual report, including its audited consolidated financial statements on Form 20-F, for the year ended... ► Artikel lesen | |
| BIONTECH | 83,45 | +2,46 % | Biotech-Werte im Check: Warum Bioxyne, Newron und BioNTech jetzt auf Substanz statt Hoffnung setzen | ||
| ERASCA | 15,560 | -8,63 % | What's Driving Erasca (ERAS)'s Nearly 355% YTD Return | ||
| EVOTEC | 4,700 | +3,84 % | Evotec-Aktie profitiert von Milliarden-Deal: Gilead kauft Tubulis | Der US-Pharmakonzern Gilead setzt seine Einkaufstour im Biotech-Sektor fort und übernimmt das deutsche Krebsforschungsunternehmen Tubulis für bis zu fünf Milliarden Dollar. Die Transaktion zeigt, wie... ► Artikel lesen | |
| ALLOGENE THERAPEUTICS | 3,415 | +25,55 % | Allogene Therapeutics, Inc.: Allogene Therapeutics Reports Interim Futility Analysis from Pivotal ALPHA3 Trial Showing 58.3% MRD Clearance with Cemacabtagene Ansegedleucel (Cema-Cel) vs. 16.7% in Observation Arm in First-Line Consolidation ... | 41.6% Absolute Difference in the Cema-Cel Arm Over the Observation Arm Exceeded Clinically Meaningful Benchmark Based on Literature of 25-30%MRD Reduction Occurred Rapidly Following Cema-Cel Treatment... ► Artikel lesen | |
| BEAM THERAPEUTICS | 29,180 | +6,30 % | Beam Therapeutics Announces Compelling Updated Clinical Data from the Ongoing Phase 1/2 Trial of BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) to Support Advancement to Pivotal Development | Treatment with 60 mg of BEAM-302 Led to Mean Steady-state Total AAT Level of 16.1 µM and All Patients Consistently and Durably Above the 11 µM Protective AAT Threshold with up to 12 Months of Follow-up... ► Artikel lesen | |
| BB BIOTECH | 50,70 | +4,43 % | Dividenden als Portfolio-Anker: Alte Bekannte Sanofi und BB Biotech - Geheimtipp RE Royalties | In einem Marktumfeld, das von strukturellen Umbrüchen geprägt ist, rückt die Stabilität des Portfolios in den Fokus. Analysten von J.P. Morgan betonen, dass der Schutz von Buchgewinnen der vergangenen... ► Artikel lesen | |
| CG ONCOLOGY | 68,18 | +0,72 % | CG Oncology, Inc. - 8-K, Current Report | ||
| REVOLUTION MEDICINES | 113,90 | +38,56 % | Meilenstein im Kampf gegen Bauchspeicheldrüsenkrebs: Revolution Medicines hebt ab! | Sie gilt als eine der Krebsarten mit dem höchsten medizinischen Bedarf: Bauchspeicheldrüsenkrebs. Die Biotech-Gesellschaft Revolution Medicines, der Übernahmeinteresse von Merck & Co nachgesagt wurde... ► Artikel lesen | |
| ARCELLX | 114,87 | +0,03 % | Laufende Fusionskontrollverfahren: Gilead Sciences, Foster City, CA/USA; Erwerb sämtlicher Anteile an und Kontrolle über die Arcellx, Redwood City, CA/USA | Datum der Anmeldung:13.03.2026Aktenzeichen:B3-41/26Unternehmen:Gilead Sciences, Foster City, CA/USA; Erwerb sämtlicher Anteile an und Kontrolle über die Arcellx, Redwood City, CA/USAProduktmärkte:Hämatologie... ► Artikel lesen | |
| IMAGENEBIO | 6,110 | +28,63 % | ImageneBio stock jumps on $30M financing | ||
| RELAY THERAPEUTICS | 15,320 | +2,41 % | Healthcare quant check: RLAY and TNGX lead Seeking Alpha's top picks ahead of Q1 earnings | ||
| COGENT BIOSCIENCES | 36,690 | +0,91 % | Cogent Biosciences, Inc.: Cogent Biosciences Announces Submission of New Drug Application for Bezuclastinib in Gastrointestinal Stromal Tumors (GIST) | Bezuclastinib NDA submitted under the FDA's RTOR program based on positive results from Phase 3 PEAK trial; bezuclastinib previously granted Breakthrough Therapy Designation in GISTBezuclastinib combination... ► Artikel lesen | |
| TANGO THERAPEUTICS | 20,830 | +4,36 % | Tango Therapeutics is the best performing healthcare stock in March | ||
| ZENTALIS PHARMACEUTICALS | 5,560 | -16,14 % | Jefferies raises Zentalis stock price target on ovarian cancer trial data |
Das Unternehmen BULLION GOLD RESOURCES CORPORATION kann der Branche Biotechnologie zugeordnet werden. Der aktuelle Kurs liegt bei 0,055 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BULLION GOLD RESOURCES CORPORATION finden Sie auf Wallstreet Online.